Qurient Co., Ltd.
Clinical-stage biopharma developing drugs for oncology, cGvHD, and tuberculosis.
115180 | KO
Overview
Corporate Details
- ISIN(s):
- KR7115180002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 242, C동 8층, 성남시
- Website:
- http://www.qurient.com/
Description
Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-10 00:00 |
증권발행결과(자율공시) (제3자배정 유상증자)
|
Korean | 5.7 KB | ||
| 2025-04-04 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.8 KB | ||
| 2025-03-26 00:00 |
정기주주총회결과
|
Korean | 18.5 KB | ||
| 2025-03-26 00:00 |
주식매수선택권부여에관한신고
|
Korean | 19.9 KB | ||
| 2025-03-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-03-18 00:00 |
사업보고서 (2024.12)
|
Korean | 428.9 KB | ||
| 2025-03-17 00:00 |
감사보고서제출
|
Korean | 25.4 KB | ||
| 2025-03-14 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 41.0 KB | ||
| 2025-03-11 00:00 |
주주총회소집결의
|
Korean | 8.2 KB | ||
| 2025-03-11 00:00 |
주주총회소집공고
|
Korean | 174.1 KB | ||
| 2025-03-11 00:00 |
의결권대리행사권유참고서류
|
Korean | 164.6 KB | ||
| 2025-01-03 00:00 |
기타시장안내 (연구개발 우수기업 매출액 특례적용 관련)
|
Korean | 2.7 KB | ||
| 2025-01-02 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정) (만성 이식편대숙주질환 환자 대상 Q702 단독치료요법의 미국 FDA…
|
Korean | 11.3 KB | ||
| 2024-12-13 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.5 KB | ||
| 2024-12-05 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (만성 이식편대숙주질환 환자 대상 Q702 단독치료요법의 미국 FDA 임상…
|
Korean | 9.5 KB |
Automate Your Workflow. Get a real-time feed of all Qurient Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Qurient Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Qurient Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
